Stock Performance
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Recent News
Upcoming & Recent Events
IR PR Contacts
Investor Contact:
Argot Partners
(212) 600-1902
Email: apellis@argotpartners.com
Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com
Receive Email Alerts
Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.
Sign Up